A Study to Assess the Efficacy, Safety, and Tolerability of CAT-354 in Subjects With Asthma

Stopped The study was terminated prematurely by the sponsor due to slow recruitment.

Conditions

• Asthma

Interventions

• OTHER: Placebo
• BIOLOGICAL: CAT-354 1 mg/kg
• BIOLOGICAL: CAT-354 5 mg/kg
• OTHER: CAT-354 10 mg/kg

Sponsor

MedImmune LLC

Collaborators

• [object Object]
• [object Object]